Indication

Severe combined immunodeficiency disease

Severe combined immunodeficiency disease is a rare, life-threatening primary immunodeficiency disorder characterized by profound defects in cellular and humoral immunity. Read more about Severe combined immunodeficiency disease

45 drugs 17 manufacturers

Advertisement

Drugs that treat it

Common Severe combined immunodeficiency disease therapies.

Showing 10–18 of 45 drugs

Filter & compare in the drug finder →Opens the drug finder with Severe combined immunodeficiency disease preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Severe combined immunodeficiency disease.

Severe combined immunodeficiency disease is a rare, life-threatening primary immunodeficiency disorder characterized by profound defects in cellular and humoral immunity.

Primarily manifesting during early infancy, it affects the immune system due to diverse monogenic mutations that severely disrupt T-lymphocyte differentiation and development, often accompanied by absent or nonfunctional B lymphocytes and natural killer cells.

Pathophysiologically, the resulting inability to mount an adaptive immune response leaves infants vulnerable to recurrent, severe, and opportunistic bacterial, viral, and fungal infections, chronic diarrhea, and failure to thrive.

Without timely intervention to restore immune function, this condition typically leads to fatal complications within the first to second year of life.

Personalize your experience

Follow Severe combined immunodeficiency disease and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it